Witida Laopajon

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular immunologyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Comparative In Vitro Apoptotic Activity of Two Chimeric Anti-CD99 Antibodies Recognizing Distinct CD99 Regions in T-ALL Models.

|Jan 10, 2026
Phenotypic Profiling and Activation-Associated Expression of CD99 Ligands on Human Leukocytes.

Myint Myat Thu, Nuchjira Takheaw, Witida Laopajon

|Nov 27, 2024
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.

Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut

|May 28, 2024
Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia.

Nuchjira Takheaw, Kamonporn Kotemul, Ratthakorn Chaiwut

|Jan 12, 2024
Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy.

Witida Laopajon, Nuchjira Takheaw, Kamonporn Kotemul

Pageof 1

Frequent Collaborators

5 joint publications

Nuchjira Takheaw

4 joint publications

Supansa Pata

1 joint publications

Kamonporn Kotemul

1 joint publications

Suradej Hongeng